A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session5s43r34e9m507v50qfq3jc255v7lh28p): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

Editorial: Global excellence in molecular immunology and therapeutics: Africa 2021. | LitMetric

Editorial: Global excellence in molecular immunology and therapeutics: Africa 2021.

Front Immunol

Microbiology, Biochemistry and Immunology Department, Morehouse School of Medicine, Atlanta, GA, United States.

Published: October 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374413PMC
http://dx.doi.org/10.3389/fimmu.2023.1247148DOI Listing

Publication Analysis

Top Keywords

editorial global
4
global excellence
4
excellence molecular
4
molecular immunology
4
immunology therapeutics
4
therapeutics africa
4
africa 2021
4
editorial
1
excellence
1
molecular
1

Similar Publications

Effects of Retinol, Natural Pea Peptide and Antioxidant Blend in a Topical Formulation: In Vitro and Clinical Evidence.

Dermatol Ther (Heidelb)

December 2024

Department of Cell Biology and Physiology, The Neuroscience Center, College of Life Sciences, Brigham Young University, Provo, UT, 84602, USA.

Introduction: Retinol has a long history of treating skin conditions, including photoaging. However, skin irritation with repeated use of retinol is well documented. The present study assessed the effectiveness of a novel topical formulation, referred to as retinol topical formulation (RTF), to improve the quality of skin health.

View Article and Find Full Text PDF

The Xavier Ochsner College of Medicine - "The Time Is Always Right To Do What Is Right".

Ochsner J

January 2024

Global Health and Education, Ochsner Clinic Foundation, New Orleans, LA and The University of Queensland Medical School, Ochsner Clinical School, New Orleans, LA.

View Article and Find Full Text PDF

The retrospective study by Lew (2022) examined the rising hospitalization rates for chronic pancreatitis (CP) and its association with pancreatic ductal adenocarcinoma (PDAC), revealing significant ethno-racial disparities and risk factors. Overweight black men aged 40-59 years and white men over 40 years with higher incomes showed an elevated risk of PDAC among CP patients. The study, which included 14.

View Article and Find Full Text PDF

Esophageal cancer (EC) is an aggressive malignancy with a poor prognosis, ranking seventh in incidence and sixth cancer-related deaths globally. EC is classified in two main types, the esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), with ESCC being more common in Eastern Europe, South Asia, and Africa, while EAC is prevalent in Western Europe and North America. Molecular analysis identifies three subgroups of ESCC, each with distinct genetic mutations and treatment responses.

View Article and Find Full Text PDF

Thirty-four per cent of deaths among Americans aged 1-46 are due to injury, and many of these deaths could be prevented if all hospitals performed as well as the highest-performing hospitals. The Institute of Medicine and the National Academies of Science, Engineering and Medicine have called for learning health systems, with emphasis on clinical practice guidelines (CPGs) as a means of limiting preventable deaths. Reduction in mortality has been demonstrated when evidence-based trauma CPGs are adhered to; however, guidelines are variably updated, redundant, absent, inaccessible, or perceived as irrelevant.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!